These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 29059190

  • 21. Mass drug administration significantly reduces infection of Schistosoma mansoni and hookworm in school children in the national control program in Sierra Leone.
    Hodges MH, Dada N, Warmsley A, Paye J, Bangura MM, Nyorkor E, Sonnie M, Zhang Y.
    BMC Infect Dis; 2012 Jan 22; 12():16. PubMed ID: 22264258
    [Abstract] [Full Text] [Related]

  • 22. Mass drug administration with praziquantel reduces the prevalence of Schistosoma mansoni and improves liver morbidity in untreated preschool children.
    Cleland CR, Tukahebwa EM, Fenwick A, Blair L.
    Trans R Soc Trop Med Hyg; 2014 Sep 22; 108(9):575-81. PubMed ID: 25059523
    [Abstract] [Full Text] [Related]

  • 23. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial.
    Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Xiao S, Tanner M.
    Lancet; 2000 Apr 15; 355(9212):1320-5. PubMed ID: 10776745
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households.
    Botros S, Sayed H, El-Dusoki H, Sabry H, Rabie I, El-Ghannam M, Hassanein M, El-Wahab YA, Engels D.
    Am J Trop Med Hyg; 2005 Feb 15; 72(2):119-23. PubMed ID: 15741544
    [Abstract] [Full Text] [Related]

  • 25. Current status of Schistosoma mansoni and the factors associated with infection two years following mass drug administration programme among primary school children in Mwea irrigation scheme: A cross-sectional study.
    Masaku J, Madigu N, Okoyo C, Njenga SM.
    BMC Public Health; 2015 Aug 01; 15():739. PubMed ID: 26231050
    [Abstract] [Full Text] [Related]

  • 26. Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration.
    Crellen T, Walker M, Lamberton PH, Kabatereine NB, Tukahebwa EM, Cotton JA, Webster JP.
    Clin Infect Dis; 2016 Nov 01; 63(9):1151-1159. PubMed ID: 27470241
    [Abstract] [Full Text] [Related]

  • 27. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL, Diaw OT, Seye MM, Faye DS, Stothard JR, Sousa-Figueiredo JC, Rollinson D.
    Acta Trop; 2013 Nov 01; 128(2):292-302. PubMed ID: 23022016
    [Abstract] [Full Text] [Related]

  • 28. Modeling Approaches to Predicting Persistent Hotspots in SCORE Studies for Gaining Control of Schistosomiasis Mansoni in Kenya and Tanzania.
    Shen Y, Sung MH, King CH, Binder S, Kittur N, Whalen CC, Colley DG.
    J Infect Dis; 2020 Feb 18; 221(5):796-803. PubMed ID: 31621850
    [Abstract] [Full Text] [Related]

  • 29. Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda.
    Frenzel K, Grigull L, Odongo-Aginya E, Ndugwa CM, Loroni-Lakwo T, Schweigmann U, Vester U, Spannbrucker N, Doehring E.
    Am J Trop Med Hyg; 1999 Jun 18; 60(6):927-31. PubMed ID: 10403322
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of the Point-of-Care Circulating Cathodic Antigen Assay for Monitoring Mass Drug Administration in a Schistosoma mansoni Control Program in Western Kenya.
    Straily A, Kavere EA, Wanja D, Wiegand RE, Montgomery SP, Mwaki A, Eleveld A, Secor WE, Odiere MR.
    Am J Trop Med Hyg; 2021 Nov 08; 106(1):303-311. PubMed ID: 34749308
    [Abstract] [Full Text] [Related]

  • 31. Identification of transmission foci of Schistosoma mansoni: narrowing the intervention target from district to transmission focus in Ethiopia.
    Tiruneh A, Kahase D, Zemene E, Tekalign E, Solomon A, Mekonnen Z.
    BMC Public Health; 2020 May 24; 20(1):769. PubMed ID: 32448159
    [Abstract] [Full Text] [Related]

  • 32. Predictive Value of School-Aged Children's Schistosomiasis Prevalence and Egg Intensity for Other Age Groups in Western Kenya.
    Mwinzi PN, Muchiri G, Wiegand RE, Omedo M, Abudho B, Karanja DM, Montgomery SP, Secor WE.
    Am J Trop Med Hyg; 2015 Dec 24; 93(6):1311-7. PubMed ID: 26416108
    [Abstract] [Full Text] [Related]

  • 33. Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe.
    Mduluza T, Jones C, Osakunor DNM, Lim R, Kuebel JK, Phiri I, Manangazira P, Tagwireyi P, Mutapi F.
    PLoS Negl Trop Dis; 2020 Jun 24; 14(6):e0008388. PubMed ID: 32569278
    [Abstract] [Full Text] [Related]

  • 34. Five-Year Follow-Up on the Prevalence and Intensity of Infections of Schistosoma mansoni in a Hard-to-Reach District of Madagascar.
    Spencer SA, Linder C, Penney JMS, Russell HJ, Hyde K, Sheehy C, Reid A, Andriamasy EH, Raderalazasoa GU, Rakotomampianina DAL, Nandimbiniaina AM, Ranaivoson TN, Andrianiaina A, Cruickshank SM, Bustinduy AL, Stothard JR, Edosoa GT, Rahetilahy AM, MADEX.
    Am J Trop Med Hyg; 2021 Mar 08; 104(5):1841-1850. PubMed ID: 33684064
    [Abstract] [Full Text] [Related]

  • 35. Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.
    Tukahebwa EM, Vennervald BJ, Nuwaha F, Kabatereine NB, Magnussen P.
    Trans R Soc Trop Med Hyg; 2013 Jun 08; 107(6):397-404. PubMed ID: 23596262
    [Abstract] [Full Text] [Related]

  • 36. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
    Shen Y, King CH, Binder S, Zhang F, Whalen CC, Evan Secor W, Montgomery SP, Mwinzi PNM, Olsen A, Magnussen P, Kinung'hi S, Phillips AE, Nalá R, Ferro J, Aurelio HO, Fleming F, Garba A, Hamidou A, Fenwick A, Campbell CH, Colley DG.
    BMC Infect Dis; 2017 Sep 29; 17(1):652. PubMed ID: 28962552
    [Abstract] [Full Text] [Related]

  • 37. Transmission of Schistosoma mansoni in Yachi areas, southwestern Ethiopia: new foci.
    Bekana T, Hu W, Liang S, Erko B.
    Infect Dis Poverty; 2019 Jan 10; 8(1):1. PubMed ID: 30626428
    [Abstract] [Full Text] [Related]

  • 38. The prevalence and intensity of Schistosoma mansoni infection among residents in two Egyptian villages, at two and twelve months post-treatment with 40 and 60 mg praziquantel per kg body weight at these two villages respectively.
    Abu-Elyazeed RR, Mansour NS, Campbell JR.
    J Egypt Soc Parasitol; 1998 Apr 10; 28(1):9-16. PubMed ID: 9617038
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern Ethiopia.
    Erko B, Degarege A, Tadesse K, Mathiwos A, Legesse M.
    Asian Pac J Trop Biomed; 2012 Mar 10; 2(3):235-9. PubMed ID: 23569905
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
    Barakat R, El Morshedy H.
    Parasitology; 2011 Apr 10; 138(4):440-6. PubMed ID: 21078223
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.